Top Senate Democrats said Thursday that the House ethics office should investigate whether stock sales by a congressman who is now one of President-elect Donald Trump’s Cabinet picks broke any laws. The Democrats cited a Wall Street Journal report last month that Rep. Tom Price, R-Ga., had traded over $300,000 worth of shares in health care companies over the past four years while pushing legislation that might affect those stocks’ values.